Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.
Nathan
N
Herrmann
David
D
Knopman
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D000077265:Donepezil; D004311:Double-Blind Method; D006801:Humans; D007189:Indans / Q000008:administration & dosage / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010352:Patient Dropouts; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D012720:Severity of Illness Index; D016896:Treatment Outcome; D028761:Withholding Treatment
D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil